Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 31, 2023
Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma.
Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma.
Journal: Journal of asthma and allergy
Published: May 20, 2022
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma.
Journal: ERJ open research
Published: August 15, 2019
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 03, 2019
Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: March 15, 2019
Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps.
Journal: The Laryngoscope
Published: September 07, 2018
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma.
Journal: The Journal of allergy and clinical immunology
Published: May 18, 2017
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.
Journal: Cardiovascular diabetology
Published: March 09, 2017
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial.
Journal: Diabetes & metabolism
Published: November 30, 2016
Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia.
Journal: Coronary artery disease
Published: October 15, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026